Follistatin — Indexed Studies

Combined resistance exercise and essential amino acid intake enhance follistatin/myostatin ratio and muscle fitness in older women: a randomized controlled trial.

Jeong D, Valentine RJ, Jeong H et al.

Higher serum follistatin levels are associated with increased vascular calcification in haemodialysis patients.

Liu C, Zhang A, Li Z

Adipo-Myokine Modulation in Obesity: Integrative Effects of Spinach Thylakoids and Functional Training in Men with Obesity: A Randomized Controlled Clinical Trial.

Razi O, Shafei A, Abdi M et al.

Lorcaserin induces abdominal fat loss with associated improvements of the circulating metabolome/lipidome and no changes in the myostatin-activin-follistatin-IGF-1 axes: A 6-month long randomized placebo-controlled clinical trial.

Ramirez-Cisneros A, Gutierrez de Piñeres V, Tamayo-Torres CS et al.

Effects of liraglutide treatment for 35-days on total and regional fat free, lean, and bone mass, and on the Myostatin-Activin-Follistatin-IGF-1 axes: a secondary analysis of a randomized placebo-controlled crossover study.

Gutierrez de Piñeres V, Ramirez-Cisneros A, Tamayo-Torres CS et al.

Effects of liraglutide treatment for 18 days on metabolic parameters, regional body composition and the myostatin-activin-follistatin-IGF-1 axis: Results from an exploratory, randomized, placebo-controlled, crossover study.

Gutierrez de Piñeres V, Tamayo-Torres CS, Ramirez-Cisneros A et al.

Cardiac rehabilitation influences serum myokine levels in patients after acute coronary syndrome: the randomised CARDIO-REH study.

Skrypnik D, Skrypnik K, Granell JC et al.

The Role of Selected Myokines in the Development of Cardiovascular Diseases, and Their Involvement in Developing Heart Failure in Rheumatoid Arthritis Patients.

Kuna J, Chmielewski G, Jaśkiewicz Ł et al.

Plasma FSTL-1 as a noninvasive diagnostic biomarker for patients with advanced liver fibrosis.

Li W, Chi Y, Xiao X et al.

Dynamic changes of systemic and local myokines in burn patients undergoing physiotherapy: A pilot prospective study.

Svecova M, Bakalar B, Vyklicka K et al.

Exploratory unsupervised machine learning of angiogenesis biomarkers in a phase II advanced cervical cancer trial of radiochemotherapy with or without neoadjuvant chemotherapy.

Arai RJ, da Costa TR, Bonadio RC et al.

FST Polymorphisms Associate with Musculoskeletal Traits and Modulate Exercise Response Differentially by Sex and Modality in Northern Han Chinese Adults.

Cao W, Gu Z, Fu R et al.

Changes in serum myostatin levels among patients with type C liver cirrhosis treated with direct-acting antivirals.

Suehiro T, Kozuru H, Matusmoto K et al.

Effects of 12-week whole-body vibration training versus resistance training in older people with sarcopenia.

Zhuang M, Gu Y, Wang Z et al.

The Effect of Exercise on Spexin and Follistatin in Elderly Individuals.

Ayaz EY, Dincer B, Cinbaz G et al.

A first-in-human study of JNJ-70218902, a bispecific T-cell-redirecting antibody against TMEFF2 in metastatic castration-resistant prostate cancer.

Calvo E, Doger B, Carles J et al.

Effects of Resistance Training on Muscular Adaptations and Inflammatory Markers in Overweight and Obese Men.

Bagheri N, Bagheri R, Mesinovic J et al.

Pasteurized Akkermansia muciniphila HB05 (HB05P) Improves Muscle Strength and Function: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Kang CH, Jung ES, Jung SJ et al.

Effectiveness of low-load resistance training with blood flow restriction vs. conventional high-intensity resistance training in older people diagnosed with sarcopenia: a randomized controlled trial.

Zhang M, Song Y, Zhu J et al.

Supplementing With Which Form of Creatine (Hydrochloride or Monohydrate) Alongside Resistance Training Can Have More Impacts on Anabolic/Catabolic Hormones, Strength and Body Composition?

Eghbali E, Arazi H, Suzuki K

Exploring the Impact of Astaxanthin Supplementation in Conjunction with a 12-Week CrossFit Training Regimen on Selected Adipo-Myokines Levels in Obese Males.

Moqaddam MA, Nemati M, Dara MM et al.

Impact of Disease Severity and Disease-Modifying Therapies on Myostatin Levels in SMA Patients.

Mackels L, Mariot V, Buscemi L et al.

Activin A-Endothelin-1 Axis Governs Pulmonary Vascular Remodeling: Mechanistic Basis for Emerging Therapies in PAH.

Faizah NN, Ryanto GRT, Kencana SMS et al.

Diagnostic Performance of Serum Adiponectin and a Biomarker-Based Model for Sarcopenia in Compensated Cirrhosis.

Boonpiraks K, Thaweesukolrat P, Surinlert P et al.

Endogenous targeting lipid nanoparticles for systemic mRNA delivery to lung cancer tumors.

Goo YT, Grigoriev V, Korzun T et al.

The Role of Follistatin-like 1 in the Cross-Talk Among Osteoclastogenesis, Bone Marrow Stromal Cell Migration, and Osteoblastogenesis In Vitro.

Piao Y, Che X, Jin X et al.

Puerarin alleviates diabetic atherosclerosis through controlling the follistatin-like 1 related inflammation.

Chen J, Hu Z, Fang M et al.

Cinnamaldehyde Regulates the EMT Process and Drug Resistance of Gastric Cancer Through FSTL3-Mediated Cytoskeletal Remodeling.

Zeng S, Yin Y, Zhang Y et al.

Canonical WNT signalling governs Echinococcus metacestode development.

Herrmann R, Herz M, Rudolf K et al.

Circulating plasma follistatin follows a 24-hour rhythm in healthy young males.

Zilstorff DB, Sennels HP, Jørgensen HL et al.

[Baicalin ameliorates obesity-related lung injury by targeting FSTL1/DIP2A signaling pathway].

Cui PL, Qi BX, Wu MD et al.

Spinal cord injury-induced overflow incontinence reshapes the activin-follistatin-inhibin axis in mouse bladder and kidney.

Shen Y, Yang S, Zhou H et al.

Targeted delivery of Follistatin-like 1 siRNA via biodegradable nanoparticles attenuates bleomycin-induced pulmonary fibrosis in mice.

Li X, Yao M, Yu M et al.

Multimodal characterization of sustained bioagent release from an epicardial depot for long-term biomaterial incorporation.

Varela CE, Monahan DS, Fan Y et al.

Assessing Aβ-independent effects of Module 42 on immune function in vitro.

Ajith I, Bakshi S, Mead E et al.

Obese adipocytes induce fibroblast-to-myofibroblast transition through TGF-β1 signaling: implications in asthma pathogenesis.

Jalaleddine N, Hachim M, Giddey A et al.

FSTL1 promotes dendritic cell pyroptosis and immunosuppression in sepsis by inhibiting STING autophagy.

Li Q, Ling H, Li J et al.

Circulating Activin A and Follistatin-like Proteins in Rheumatoid Arthritis with Interstitial Lung Disease: A Cross-Sectional Comparative Study.

Ulutaş F, Kaya K, Yiğit N et al.

Polygonatum cyrtonema Hua fructan ameliorates ulcerative colitis via gut microbiota modulation and follistatin targeting.

Xu Q, Lv Q, Yang Z et al.

Serum FSTL-1 and AI-assessed muscle parameters in cancer-related malnutrition.

de Luis D, Primo D, Izaola O et al.

FSTL1 contribute to aggressive clinical behavior in DLBCL may by activating the DIP2A/ICAM-1-mediated adhesion mechanism.

Liang X, Zhang X, Wang C et al.

Potential new biomarkers in pig saliva for differentiating between the effects of different conditions of mixing and density at pre-slaughter: A preliminary proteomicstudy.

Botía M, Muñoz-Prieto A, Ortín Bustillo A et al.

Effect of exercise on hormonal responses in adolescents with obesity and leptin resistance: a randomized trial.

Jeong D, Valentine RJ, Park K et al.

ZNF454-FSTL3 axis inhibits colorectal cancer progression by inhibiting HIF-1α-mediated glycolysis in hypoxia.

Tang P, Wu Y, Tan L et al.

Targeting brain insulin signaling to combat metabolic disorders.

Metz M, Fenselau H

Systemic angiogenic protein changes following propranolol therapy in infantile hemangioma: a multi-target perspective.

Liang L, Zhang Y, Ma Y et al.

Effects of Ovariectomy and Sex Steroids on Prolactin Synthesis.

Cairang Z, Kanasaki H, Tumurbaatar T et al.

Follistatin-like 1: a novel biomarker with a potential link to obstructive sleep apnea severity and treatment efficacy.

Alterki A, Abu-Farha M, Al Shawaf E et al.

Identification of myokines associated with the pathological stress response in the mdx mouse model of Duchenne muscular dystrophy.

Johnson EE, Powers J, Ervasti JM

Myostatin Function during In Vitro Myogenesis: Considerations for Knockout-Based Mechanistic Analysis.

Suh J, Baik J, Lee YS